Laurent Dumartin
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
From development to cancer - an ever-increasing role of AGR2.
Journal: American journal of cancer research
Published: April 22, 2021
AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting.
Journal: Oncotarget
Published: March 05, 2019
Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling.
Journal: Molecular oncology
Published: May 16, 2018
Splice variants as novel targets in pancreatic ductal adenocarcinoma.
Journal: Scientific reports
Published: March 10, 2017
ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation.
Journal: Oncogene
Published: June 14, 2016
Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer.
Journal: Cancer research
Published: October 15, 2015
Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma.
Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 05, 2015
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.
Journal: Genome medicine
Published: June 26, 2014
AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D.
Journal: Cancer research
Published: September 28, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026